A Head-to-head Comparison between SurgiMend and Epiflex in 127 Breast Reconstructions

por Eichler, Christian, Vogt, Nadine, Brunnert, Klaus, Sauerwald, Axel, Puppe, Julian, Warm, Mathias
Publicado 2015

Inframammary Fold Reconstruction: A Biomechanical Analysis

por Eichler, Christian, Schell, Julia, Uener, Jens, Prescher, Andreas, Scaal, Martin, Puppe, Julian, Warm, Mathias
Publicado 2016

Correlation analysis of resected breast tissue and implant volume after mastectomy and its association with breast density

por Malter, Wolfram, Bachmann, Bo Jan, Krug, Barbara, Hellmich, Martin, Zinser, Max, Mallmann, Peter, Eichler, Christian, Puppe, Julian
Publicado 2021

Neoadjuvant Therapy of Cervical Carcinoma with the Angiogenesis Inhibitor Bevacizumab: a Single-Centre Analysis

por Junker, Philip, Puppe, Julian, Thangarajah, Fabinshy, Domröse, Christian, Cepic, Angela, Morgenstern, Bernd, Ratiu, Dominik, Hellmich, Martin, Mallmann, Peter, Wirtz, Marina
Publicado 2018

The conjugated antimetabolite 5-FdU-ECyd and its cellular and molecular effects on platinum-sensitive vs. -resistant ovarian cancer cells in vitro

por Schott, Sarah, Wimberger, Pauline, Klink, Barbara, Grützmann, Konrad, Puppe, Julian, Wauer, Ulrike Sophie, Klotz, Daniel Martin, Schröck, Evelin, Kuhlmann, Jan Dominik
Publicado 2017

Platelet-rich plasma (PRP) in oncological patients: long-term oncological outcome analysis of the treatment of subcutaneous venous access device scars in 89 breast cancer patients

por Eichler, Christian, Üner, Jens, Thangarajah, Fabinshy, Radosa, Julia, Zinser, Max, Fischer, Lotta Ada, Puppe, Julian, Warm, Matthias, Malter, Wolfram, Lenz, Caroline
Publicado 2022

Trophoblast Cell Surface Antigen 2 (TROP2) as a Predictive Bio-Marker for the Therapeutic Efficacy of Sacituzumab Govitecan in Adenocarcinoma of the Esophagus

por Hoppe, Sascha, Meder, Lydia, Gebauer, Florian, Ullrich, Roland T., Zander, Thomas, Hillmer, Axel M., Buettner, Reinhard, Plum, Patrick, Puppe, Julian, Malter, Wolfram, Quaas, Alexander
Publicado 2022

BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A

por Puppe, Julian, Drost, Rinske, Liu, Xiaoling, Joosse, Simon A, Evers, Bastiaan, Cornelissen-Steijger, Paulien, Nederlof, Petra, Yu, Qiang, Jonkers, Jos, van Lohuizen, Maarten, Pietersen, Alexandra M
Publicado 2009

The 3q Oncogene SEC62 Predicts Response to Neoadjuvant Chemotherapy and Regulates Tumor Cell Migration in Triple Negative Breast Cancer

por Radosa, Julia C., Kasoha, Mariz, Doerk, Merle, Cullmann, Annika, Kaya, Askin C., Linxweiler, Maximilian, Radosa, Marc P., Takacs, Zoltan, Tirincsi, Andrea, Lang, Sven, Jung, Martin, Puppe, Julian, Linxweiler, Barbara, Wagner, Mathias, Bohle, Rainer M., Solomayer, Erich-Franz, Zimmermann, Julia S. M.
Publicado 2023

Combined inhibition of EZH2 and ATM is synthetic lethal in BRCA1-deficient breast cancer

por Ratz, Leonie, Brambillasca, Chiara, Bartke, Leandra, Huetzen, Maxim A., Goergens, Jonas, Leidecker, Orsolya, Jachimowicz, Ron D., van de Ven, Marieke, Proost, Natalie, Siteur, Bjørn, de Korte-Grimmerink, Renske, Bouwman, Peter, Pulver, Emilia M., de Bruijn, Roebi, Isensee, Jörg, Hucho, Tim, Pandey, Gaurav, van Lohuizen, Maarten, Mallmann, Peter, Reinhardt, Hans Christian, Jonkers, Jos, Puppe, Julian
Publicado 2022